Analysts have recently evaluated Sangamo Therapeutics and provided 12-month price targets. The average target is $8.09, accompanied by a high estimate of $10.00 and a low estimate of $2.00. Surpassing ...

Evidence for such a prion-like propagation mechanism has ... the regional spreading pattern is contiguous in many ALS patients, implying that propagation does contribute to progression of this disease ...

Rhode Island Hospital at Brown University Health will receive $1 million to demonstrate proof of concept for a test that uses ...

In other developments, the WHO says violence in the eastern DR Congo complicates the country's mpox response and that ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

New Delhi: Patient advocacy groups have called upon the Union Health Ministry to address critical delays in the implementation of the ₹974 crore national programme for rare disease patients ...

Rare diseases are challenging to identify, and the relatively small number of patients suffering from these diseases are dispersed across the globe. The Chan Zuckerberg Initiative, a nonprofit ...

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

In part three of five articles by Siren Interactive, Eileen O’Brien discusses how important patient registries are for the acceleration of orphan drugs and the awareness of rare diseases ...

In 2022, more than 941,600 Americans died from cardiovascular disease. Heart disease remains the leading cause of death in the United States, according to a new report. The American Heart ...